Hence, in the context of future clinical trials and the GABPA gene network (Figure 9), it is possible to suggest some alternative options for clinical treatments to improve BC patient outcomes: i) traditional chemotherapy combined with anti-spliceosome treatment and ii) anti-proteasome therapy combined with anti-spliceosome treatment. The gene discussed is GABPA; the disease is breast cancer.